Cui Ling, Schroeder Pamela R, Sack Paul A
Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD.
Clin Diabetes. 2020 Dec;38(5):462-473. doi: 10.2337/cd20-0054.
Several new technologies use computer algorithms to analyze a person's blood glucose response to insulin treatment, calculate the person's next recommended insulin dose, advise the person regarding when to check blood glucose next, and provide alerts regarding glucose control for the individual patient or across a hospital system. This article reviews U.S. Food and Drug Administration (FDA)-approved products designed to help manage insulin dosing for inpatients, as well as those available to provide people with insulin-requiring diabetes support in making adjustments to their basal and/or mealtime insulin doses. Many of these products have a provider interface that allows for remote monitoring of patients' glucose readings and insulin doses. By alleviating some of the burdens of insulin initiation and dose adjustment, these products may facilitate improved glycemic management and patient outcomes.
几种新技术利用计算机算法来分析一个人的血糖对胰岛素治疗的反应，计算该人的下一次推荐胰岛素剂量，就下次何时检测血糖向该人提供建议，并针对个体患者或整个医院系统提供血糖控制警报。本文回顾了美国食品药品监督管理局（FDA）批准的旨在帮助管理住院患者胰岛素剂量的产品，以及那些可用于为需要胰岛素治疗的糖尿病患者在调整基础和/或餐时胰岛素剂量方面提供支持的产品。这些产品中的许多都有一个提供者界面，允许远程监测患者的血糖读数和胰岛素剂量。通过减轻胰岛素起始和剂量调整的一些负担，这些产品可能有助于改善血糖管理和患者预后。
